Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Copper homeostasis and cuproptosis in Alzheimer's disease (Review). | Int J Mol Med | 2025 | 40849807 | PubTator, text mining | PubMed |
| Spinal cord ischemia reperfusion injury induces cuproptosis in neurons. | Cell Biosci | 2025 | 40841965 | PubTator, text mining | PubMed |
| Identification and immunological characterization of cuproptosis-related molecular clusters in cardioembolic stroke. | Medicine (Baltimore) | 2025 | 40826682 | PubTator, text mining | PubMed |
| Copper-overload promotes ferroptosis in cervical cancer cells by upregulating HMOX1 expression. | Discov Oncol | 2025 | 40810778 | PubTator, text mining | PubMed |
| Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma. | Front Oncol | 2025 | 40809021 | PubTator, text mining | PubMed |
| Mechanisms of copper metabolism and cuproptosis: implications for liver diseases. | Front Immunol | 2025 | 40808953 | PubTator, text mining | PubMed |
| Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis. | Front Immunol | 2025 | 40808944 | PubTator, text mining | PubMed |
| Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)/microRNA-302a-3p (miR-302a-3p)/ATPase Copper Transporting Beta (ATP7B) Axis. | MedComm (2020) | 2025 | 40761482 | PubTator, text mining | PubMed |
| Deciphering Cuproptosis in Sepsis: Mechanisms, Consequences, and Therapeutic Opportunities. | J Inflamm Res | 2025 | 40735271 | PubTator, text mining | PubMed |
| Targeting Intratumoral Copper Inhibits Tumor Progression via p62-Mediated EZH2 Degradation and Potentiates Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2025 | 40719074 | PubTator, text mining | PubMed |
| Hypoxia, cuproptosis, and osteoarthritis: Unraveling the molecular crosstalk. | Redox Biol | 2025 | 40669206 | PubTator, text mining | PubMed |
| TRIM21-Mediated K11-Linked Ubiquitination of ID1 Suppresses Tumorigenesis and Promotes Cuproptosis in Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2025 | 40652518 | PubTator, text mining | PubMed |
| The potential role of cuproptosis-related genes for therapy and immunoregulation in pan-cancer. | PLoS One | 2025 | 40601654 | PubTator, text mining | PubMed |
| Unveiling the Cuproptosis in Colitis and Colitis-Related Carcinogenesis: A Multifaceted Player and Immune Moderator. | Research (Wash D C) | 2025 | 40370501 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals SLC31A1-mediated M2 polarization of macrophages promotes malignant progression in triple-negative breast cancer. | J Cancer Res Clin Oncol | 2025 | 40360897 | PubTator, text mining | PubMed |
| Copper's new role in cancer: how cuproptosis-related genes could revolutionize glioma treatment. | BMC Cancer | 2025 | 40355831 | PubTator, text mining | PubMed |
| Comparison of PD-L1, CTR-1, VEGF, and p53 expression in sensitive and resistant epithelial ovarian cancer (EOC) patients to platinum-based chemotherapy. | Narra J | 2025 | 40352174 | PubTator, text mining | PubMed |
| Mechanism of S-Palmitoylation in Polystyrene Nanoplastics-Induced Macrophage Cuproptosis Contributing to Emphysema through Alveolar Epithelial Cell Pyroptosis. | ACS Nano | 2025 | 40335889 | PubTator, text mining | PubMed |
| How Cells Die in Psoriasis? | Int J Mol Sci | 2025 | 40332377 | PubTator, text mining | PubMed |
| Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer. | Front Immunol | 2025 | 40292291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=6